Incidence, risk factors, timing, and outcome of influenza versus COVID-19-associated putative invasive aspergillosis
Infect Control Hosp Epidemiol
.
2021 Sep;42(9):1149-1150.
doi: 10.1017/ice.2020.460.
Epub 2020 Sep 9.
Authors
Camille Sarrazyn
1
,
Sofie Dhaese
1
,
Birgit Demey
2
,
Stefaan Vandecasteele
1
,
Marijke Reynders
3
,
Jens T Van Praet
1
4
Affiliations
1
Department of Nephrology and Infectious Diseases, AZ Sint-Jan Brugge-Oostende AV, Brugge, Belgium.
2
Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium.
3
Department of Laboratory Medicine, Medical Microbiology, AZ Sint-Jan Brugge-Oostende AV, Brugge, Belgium.
4
Department of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium.
PMID:
32900411
PMCID:
PMC8160496
DOI:
10.1017/ice.2020.460
No abstract available
MeSH terms
Aspergillosis* / epidemiology
COVID-19*
Humans
Incidence
Influenza, Human* / epidemiology
Risk Factors
SARS-CoV-2